Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Transfection of NF-κB decoy oligodeoxynucleotide suppresses pulmonary metastasis by murine osteosarcoma

Abstract

Nuclear factor-kappa B (NF-κB) has a pivotal role in the progression and distant metastasis of cancers, including malignant bone tumors. To inhibit NF-κB activation, a new molecular therapy using synthetic double-stranded oligodeoxynucleotide (ODN) as a ‘decoy’ cis element against NF-κB has been developed. To determine whether pulmonary metastasis of osteosarcoma is reduced by inhibiting the action of NF-κB, NF-κB decoy ODN was transfected into the nuclei of murine osteosarcoma cells with high pulmonary metastatic potential, the LM8 cell line, using a three-dimensional alginate spheroid culture model. An in vitro study demonstrated the successful transfection of LM8 cells cultured in alginate beads by ‘naked’ NF-κB decoy ODN and that the activation of NF-κB signaling was significantly suppressed. Tumor growth was not affected by transfection of NF-κB decoy ODN, however, the expression of vascular endothelial growth factor (VEGF) and intercellular adhesion molecule 1 (ICAM-1) mRNA was markedly decreased. Furthermore, the transfection of ‘naked’ NF-κB decoy ODN effectively suppressed pulmonary metastasis in an in vivo alginate bead transplantation model. Our results suggest that NF-κB has a central and specific role in the regulation of tumor metastasis and could be a molecular target for development of anti-metastatic treatments for osteosarcoma.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  1. Uchida A, Myoui A, Araki N, Yoshikawa H, Shinto Y, Ueda T . Neoadjuvant chemotherapy for pediatric osteosarcoma patients. Cancer 1997; 79: 411–415.

    Article  CAS  Google Scholar 

  2. Thanos D, Maniatis T . NF-kappa B: a lesson in family values. Cell 1995; 80: 529–532.

    Article  CAS  Google Scholar 

  3. Baldwin Jr AS . The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 1996; 14: 649–683.

    Article  CAS  Google Scholar 

  4. Ravi R, Bedi A . NF-kappaB in cancer—a friend turned foe. Drug Resist Updat 2004; 7: 53–67.

    Article  CAS  Google Scholar 

  5. Meyskens Jr FL, Buckmeier JA, McNulty SE, Tohidian NB . Activation of nuclear factor-kappa B in human metastatic melanoma cells and the effect of oxidative stress. Clin Cancer Res 1999; 5: 1197–1202.

    CAS  PubMed  Google Scholar 

  6. Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet Jr RJ, Sledge Jr GW . Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth. Mol Cell Biol 1997; 17: 3629–3639.

    Article  CAS  Google Scholar 

  7. Yokoo T, Kitamura M . Dual regulation of IL-1 beta-mediated matrix metalloproteinase-9 expression in mesangial cells by NF-kappa B and AP-1. Am J Physiol 1996; 270: F123–F130.

    CAS  PubMed  Google Scholar 

  8. Yoshida S, Ono M, Shono T, Izumi H, Ishibashi T, Suzuki H et al. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol Cell Biol 1997; 17: 4015–4023.

    Article  CAS  Google Scholar 

  9. Park BK, Zhang H, Zeng Q, Dai J, Keller ET, Giordano T et al. NF-kappaB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF. Nat Med 2007; 13: 62–69.

    Article  CAS  Google Scholar 

  10. Huang S, Pettaway CA, Uehara H, Bucana CD, Fidler IJ . Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis. Oncogene 2001; 20: 4188–4197.

    Article  CAS  Google Scholar 

  11. Huang S, DeGuzman A, Bucana CD, Fidler IJ . Nuclear factor-kappaB activity correlates with growth, angiogenesis, and metastasis of human melanoma cells in nude mice. Clin Cancer Res 2000; 6: 2573–2581.

    CAS  PubMed  Google Scholar 

  12. Andela VB, Sheu TJ, Puzas EJ, Schwarz EM, O’Keefe RJ, Rosier RN . Malignant reversion of a human osteosarcoma cell line, Saos-2, by inhibition of NFkappaB. Biochem Biophys Res Commun 2002; 297: 237–241.

    Article  CAS  Google Scholar 

  13. Andela VB, Siddiqui F, Groman A, Rosier RN . An immunohistochemical analysis to evaluate an inverse correlation between Runx2/Cbfa1 and NF kappa B in human osteosarcoma. J Clin Pathol 2005; 58: 328–330.

    Article  CAS  Google Scholar 

  14. Asai T, Tomita Y, Nakatsuka S, Hoshida Y, Myoui A, Yoshikawa H et al. VCP (p97) regulates NFkappaB signaling pathway, which is important for metastasis of osteosarcoma cell line. Jpn J Cancer Res 2002; 93: 296–304.

    Article  CAS  Google Scholar 

  15. Harimaya K, Tanaka K, Matsumoto Y, Sato H, Matsuda S, Iwamoto Y . Antioxidants inhibit TNFalpha-induced motility and invasion of human osteosarcoma cells: possible involvement of NFkappaB activation. Clin Exp Metastasis 2000; 18: 121–129.

    Article  CAS  Google Scholar 

  16. Kishida Y, Yoshikawa H, Myoui A . Parthenolide, a natural inhibitor of Nuclear Factor-kappaB, inhibits lung colonization of murine osteosarcoma cells. Clin Cancer Res 2007; 13: 59–67.

    Article  CAS  Google Scholar 

  17. Mori K, Le Goff B, Berreur M, Riet A, Moreau A, Blanchard F et al. Human osteosarcoma cells express functional receptor activator of nuclear factor-kappa B. J Pathol 2007; 211: 555–562.

    Article  CAS  Google Scholar 

  18. Morishita R, Sugimoto T, Aoki M, Kida I, Tomita N, Moriguchi A et al. In vivo transfection of cis element ‘decoy’ against nuclear factor-kappaB binding site prevents myocardial infarction. Nat Med 1997; 3: 894–899.

    Article  CAS  Google Scholar 

  19. Morishita R, Tomita N, Kaneda Y, Ogihara T . Molecular therapy to inhibit NFkappaB activation by transcription factor decoy oligonucleotides. Curr Opin Pharmacol 2004; 4: 139–146.

    Article  CAS  Google Scholar 

  20. Kawamura I, Morishita R, Tomita N, Lacey E, Aketa M, Tsujimoto S et al. Intratumoral injection of oligonucleotides to the NF kappa B binding site inhibits cachexia in a mouse tumor model. Gene Ther 1999; 6: 91–97.

    Article  CAS  Google Scholar 

  21. Kawamura I, Morishita R, Tsujimoto S, Manda T, Tomoi M, Tomita N et al. Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice. Gene Ther 2001; 8: 905–912.

    Article  CAS  Google Scholar 

  22. Asai T, Ueda T, Itoh K, Yoshioka K, Aoki Y, Mori S et al. Establishment and characterization of a murine osteosarcoma cell line (LM8) with high metastatic potential to the lung. Int J Cancer 1998; 76: 418–422.

    Article  CAS  Google Scholar 

  23. Akeda K, Nishimura A, Satonaka H, Shintani K, Kusuzaki K, Matsumine A et al. Three-dimensional alginate spheroid culture system of murine osteosarcoma. Oncol Rep 2009; 22: 997–1003.

    Article  CAS  Google Scholar 

  24. Dunn TB, Andervont HB . Histology of some neoplasms and non-neoplastic lesions found in wild mice maintained under laboratory conditions. J Natl Cancer Inst 1963; 31: 873–901.

    CAS  PubMed  Google Scholar 

  25. Masuda K, Takegami K, An H, Kumano F, Chiba K, Andersson GB et al. Recombinant osteogenic protein-1 upregulates extracellular matrix metabolism by rabbit annulus fibrosus and nucleus pulposus cells cultured in alginate beads. J Orthop Res 2003; 21: 922–930.

    Article  CAS  Google Scholar 

  26. Renard P, Ernest I, Houbion A, Art M, Le Calvez H, Raes M et al. Development of a sensitive multi-well colorimetric assay for active NFkappaB. Nucleic Acids Res 2001; 29: E21.

    Article  CAS  Google Scholar 

  27. Imai Y, Miyamoto K, An HS, Thonar EJ, Andersson GB, Masuda K . Recombinant human osteogenic protein-1 upregulates proteoglycan metabolism of human anulus fibrosus and nucleus pulposus cells. Spine 2007; 32: 1303–1309;discussion 1310.

    Article  Google Scholar 

  28. Matsumine A, Shintani K, Kusuzaki K, Matsubara T, Satonaka H, Wakabayashi T et al. Expression of decorin, a small leucine-rich proteoglycan, as a prognostic factor in soft tissue tumors. J Surg Oncol 2007; 96: 411–418.

    Article  CAS  Google Scholar 

  29. Horiuchi K, Morioka H, Nishimoto K, Suzuki Y, Susa M, Nakayama R et al. Growth suppression and apoptosis induction in synovial sarcoma cell lines by a novel NF-kappaB inhibitor, dehydroxymethylepoxyquinomicin (DHMEQ). Cancer Lett 2008; 272: 336–344.

    Article  CAS  Google Scholar 

  30. Wu JM, Sheng H, Saxena R, Skill NJ, Bhat-Nakshatri P, Yu M et al. NF-kappaB inhibition in human hepatocellular carcinoma and its potential as adjunct to sorafenib based therapy. Cancer Lett 2009; 278: 145–155.

    Article  CAS  Google Scholar 

  31. Nishimura D, Ishikawa H, Matsumoto K, Shibata H, Motoyoshi Y, Fukuta M et al. DHMEQ, a novel NF-kappaB inhibitor, induces apoptosis and cell-cycle arrest in human hepatoma cells. Int J Oncol 2006; 29: 713–719.

    CAS  PubMed  Google Scholar 

  32. Horiguchi Y, Kuroda K, Nakashima J, Murai M, Umezawa K . Antitumor effect of a novel nuclear factor-kappa B activation inhibitor in bladder cancer cells. Expert Rev Anticancer Ther 2003; 3: 793–798.

    Article  CAS  Google Scholar 

  33. Zucchini C, Rocchi A, Manara MC, De Sanctis P, Capanni C, Bianchini M et al. Apoptotic genes as potential markers of metastatic phenotype in human osteosarcoma cell lines. Int J Oncol 2008; 32: 17–31.

    CAS  PubMed  Google Scholar 

  34. Um JH, Kwon JK, Kang CD, Kim MJ, Ju DS, Bae JH et al. Relationship between antiapoptotic molecules and metastatic potency and the involvement of DNA-dependent protein kinase in the chemosensitization of metastatic human cancer cells by epidermal growth factor receptor blockade. J Pharmacol Exp Ther 2004; 311: 1062–1070.

    Article  CAS  Google Scholar 

  35. Folkman J . The role of angiogenesis in tumor growth. Semin Cancer Biol 1992; 3: 65–71.

    CAS  PubMed  Google Scholar 

  36. Huang WC, Chan ST, Yang TL, Tzeng CC, Chen CC . Inhibition of ICAM-1 gene expression, monocyte adhesion and cancer cell invasion by targeting IKK complex: molecular and functional study of novel alpha-methylene-gamma-butyrolactone derivatives. Carcinogenesis 2004; 25: 1925–1934.

    Article  CAS  Google Scholar 

  37. Lee YH, Tokunaga T, Oshika Y, Suto R, Yanagisawa K, Tomisawa M et al. Cell-retained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcoma. Eur J Cancer 1999; 35: 1089–1093.

    Article  CAS  Google Scholar 

  38. Lin YC, Shun CT, Wu MS, Chen CC . A novel anticancer effect of thalidomide: inhibition of intercellular adhesion molecule-1-mediated cell invasion and metastasis through suppression of nuclear factor-kappaB. Clin Cancer Res 2006; 12: 7165–7173.

    Article  CAS  Google Scholar 

  39. Tannock IF, Hill RP, Bristow RG, Harrington L . Tumor Progressin and Metastasis: Cellular, Molecular, and Microenvironment Factors. In: Khokha R, Voura E, Hill RP (eds). The Basic Science of Oncology, Fourth edn The McGraw-Hill Companies, Inc.: New York, 2004, pp 205–230.

    Google Scholar 

  40. Roque F, Mon G, Belardi J, Rodriguez A, Grinfeld L, Long R et al. Safety of intracoronary administration of c-myc antisense oligomers after percutaneous transluminal coronary angioplasty (PTCA). Antisense Nucleic Acid Drug Dev 2001; 11: 99–106.

    Article  CAS  Google Scholar 

  41. Miyao T, Takakura Y, Akiyama T, Yoneda F, Sezaki H, Hashida M . Stability and pharmacokinetic characteristics of oligonucleotides modified at terminal linkages in mice. Antisense Res Dev 1995; 5: 115–121.

    Article  CAS  Google Scholar 

  42. Higuchi Y, Kawakami S, Oka M, Yabe Y, Yamashita F, Hashida M . Intravenous administration of mannosylated cationic liposome/NFkappaB decoy complexes effectively prevent LPS-induced cytokine production in a murine liver failure model. FEBS Lett 2006; 580: 3706–3714.

    Article  CAS  Google Scholar 

  43. De Vry CG, Prasad S, Komuves L, Lorenzana C, Parham C, Le T et al. Non-viral delivery of nuclear factor-kappaB decoy ameliorates murine inflammatory bowel disease and restores tissue homeostasis. Gut 2007; 56: 524–533.

    Article  CAS  Google Scholar 

  44. Desmet C, Gosset P, Pajak B, Cataldo D, Bentires-Alj M, Lekeux P et al. Selective blockade of NF-kappa B activity in airway immune cells inhibits the effector phase of experimental asthma. J Immunol 2004; 173: 5766–5775.

    Article  CAS  Google Scholar 

  45. Inagaki H, Suzuki J, Ogawa M, Taniyama Y, Morishita R, Isobe M . Ultrasound-microbubble-mediated NF-kappaB decoy transfection attenuates neointimal formation after arterial injury in mice. J Vasc Res 2006; 43: 12–18.

    Article  CAS  Google Scholar 

  46. Azuma H, Tomita N, Sakamoto T, Kiyama S, Inamoto T, Takahara K et al. Marked regression of liver metastasis by combined therapy of ultrasound-mediated NF kappaB-decoy transfer and transportal injection of paclitaxel, in mouse. Int J Cancer 2008; 122: 1645–1656.

    Article  CAS  Google Scholar 

  47. Matsubara T, Akeda K, Nishimura A, Kusuzaki K, Matsumine A, Shintani K et al. Injection of naked decoy oligodeoxynucleotide against nuclear factor-kappa B into a murine osteosarcoma in a spontaneous pulmonary metastasis model. Trans Orthop Res Soc 2008; 33: 1196.

    Google Scholar 

Download references

Acknowledgements

We thank Takahiro Iino and Kei Chiba for their technical assistance. This study was sponsored by grants from the Uehara Memorial Life Science Foundation and from the Ministry of Education, Culture, Sports, Science and Technology (Japan).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K Akeda.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nishimura, A., Akeda, K., Matsubara, T. et al. Transfection of NF-κB decoy oligodeoxynucleotide suppresses pulmonary metastasis by murine osteosarcoma. Cancer Gene Ther 18, 250–259 (2011). https://doi.org/10.1038/cgt.2010.75

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/cgt.2010.75

Keywords

This article is cited by

Search

Quick links